Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sickle Cell Anemia
1.2.3 Sickle Beta Thalassemia
1.2.4 Sickle Hemoglobin C Disease
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Treatment Market Perspective (2018-2029)
2.2 Sickle Cell Disease Treatment Growth Trends by Region
2.2.1 Global Sickle Cell Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sickle Cell Disease Treatment Historic Market Size by Region (2018-2024)
2.2.3 Sickle Cell Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Sickle Cell Disease Treatment Market Dynamics
2.3.1 Sickle Cell Disease Treatment Industry Trends
2.3.2 Sickle Cell Disease Treatment Market Drivers
2.3.3 Sickle Cell Disease Treatment Market Challenges
2.3.4 Sickle Cell Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Disease Treatment Players by Revenue
3.1.1 Global Top Sickle Cell Disease Treatment Players by Revenue (2018-2024)
3.1.2 Global Sickle Cell Disease Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Disease Treatment Revenue
3.4 Global Sickle Cell Disease Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatment Revenue in 2022
3.5 Sickle Cell Disease Treatment Key Players Head office and Area Served
3.6 Key Players Sickle Cell Disease Treatment Product Solution and Service
3.7 Date of Enter into Sickle Cell Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Treatment Historic Market Size by Type (2018-2024)
4.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Sickle Cell Disease Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Treatment Historic Market Size by Application (2018-2024)
5.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sickle Cell Disease Treatment Market Size (2018-2029)
6.2 North America Sickle Cell Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sickle Cell Disease Treatment Market Size by Country (2018-2024)
6.4 North America Sickle Cell Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Disease Treatment Market Size (2018-2029)
7.2 Europe Sickle Cell Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sickle Cell Disease Treatment Market Size by Country (2018-2024)
7.4 Europe Sickle Cell Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Sickle Cell Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle Cell Disease Treatment Market Size (2018-2029)
9.2 Latin America Sickle Cell Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sickle Cell Disease Treatment Market Size by Country (2018-2024)
9.4 Latin America Sickle Cell Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Sickle Cell Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sickle Cell Disease Treatment Introduction
11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Sickle Cell Disease Treatment Introduction
11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.2.5 Eli Lilly Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Sickle Cell Disease Treatment Introduction
11.3.4 Novartis Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle Cell Disease Treatment Introduction
11.4.4 Pfizer Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.4.5 Pfizer Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Sickle Cell Disease Treatment Introduction
11.5.4 Baxter Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.5.5 Baxter Recent Development
11.6 Emmaus Life Sciences
11.6.1 Emmaus Life Sciences Company Detail
11.6.2 Emmaus Life Sciences Business Overview
11.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Introduction
11.6.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.6.5 Emmaus Life Sciences Recent Development
11.7 Bluebird bio
11.7.1 Bluebird bio Company Detail
11.7.2 Bluebird bio Business Overview
11.7.3 Bluebird bio Sickle Cell Disease Treatment Introduction
11.7.4 Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.7.5 Bluebird bio Recent Development
11.8 Blood Therapeutics
11.8.1 Blood Therapeutics Company Detail
11.8.2 Blood Therapeutics Business Overview
11.8.3 Blood Therapeutics Sickle Cell Disease Treatment Introduction
11.8.4 Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.8.5 Blood Therapeutics Recent Development
11.9 Sangamo Therapeutics
11.9.1 Sangamo Therapeutics Company Detail
11.9.2 Sangamo Therapeutics Business Overview
11.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Introduction
11.9.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.9.5 Sangamo Therapeutics Recent Development
11.10 Acceleron Pharma
11.10.1 Acceleron Pharma Company Detail
11.10.2 Acceleron Pharma Business Overview
11.10.3 Acceleron Pharma Sickle Cell Disease Treatment Introduction
11.10.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.10.5 Acceleron Pharma Recent Development
11.11 Arena Pharmaceuticals
11.11.1 Arena Pharmaceuticals Company Detail
11.11.2 Arena Pharmaceuticals Business Overview
11.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.11.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.11.5 Arena Pharmaceuticals Recent Development
11.12 Alnylam Pharmaceuticals
11.12.1 Alnylam Pharmaceuticals Company Detail
11.12.2 Alnylam Pharmaceuticals Business Overview
11.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.12.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.12.5 Alnylam Pharmaceuticals Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Sickle Cell Disease Treatment Introduction
11.13.4 Sanofi Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.13.5 Sanofi Recent Development
11.14 CRISPR Therapeutics
11.14.1 CRISPR Therapeutics Company Detail
11.14.2 CRISPR Therapeutics Business Overview
11.14.3 CRISPR Therapeutics Sickle Cell Disease Treatment Introduction
11.14.4 CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.14.5 CRISPR Therapeutics Recent Development
11.15 Vertex Pharmaceuticals, Inc.
11.15.1 Vertex Pharmaceuticals, Inc. Company Detail
11.15.2 Vertex Pharmaceuticals, Inc. Business Overview
11.15.3 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Introduction
11.15.4 Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.15.5 Vertex Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sickle Cell Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sickle Cell Anemia
Table 3. Key Players of Sickle Beta Thalassemia
Table 4. Key Players of Sickle Hemoglobin C Disease
Table 5. Global Sickle Cell Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Sickle Cell Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Sickle Cell Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Sickle Cell Disease Treatment Market Share by Region (2018-2024)
Table 9. Global Sickle Cell Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Sickle Cell Disease Treatment Market Share by Region (2024-2029)
Table 11. Sickle Cell Disease Treatment Market Trends
Table 12. Sickle Cell Disease Treatment Market Drivers
Table 13. Sickle Cell Disease Treatment Market Challenges
Table 14. Sickle Cell Disease Treatment Market Restraints
Table 15. Global Sickle Cell Disease Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Sickle Cell Disease Treatment Market Share by Players (2018-2024)
Table 17. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2022)
Table 18. Ranking of Global Top Sickle Cell Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sickle Cell Disease Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sickle Cell Disease Treatment Product Solution and Service
Table 22. Date of Enter into Sickle Cell Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2024)
Table 26. Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Sickle Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2024)
Table 30. Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Sickle Cell Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Sickle Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Sickle Cell Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Sickle Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Sickle Cell Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Sickle Cell Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Sickle Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Sickle Cell Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. AstraZeneca Company Detail
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Sickle Cell Disease Treatment Product
Table 50. AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Sickle Cell Disease Treatment Product
Table 55. Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Sickle Cell Disease Treatment Product
Table 60. Novartis Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Sickle Cell Disease Treatment Product
Table 65. Pfizer Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Baxter Company Detail
Table 68. Baxter Business Overview
Table 69. Baxter Sickle Cell Disease Treatment Product
Table 70. Baxter Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 71. Baxter Recent Development
Table 72. Emmaus Life Sciences Company Detail
Table 73. Emmaus Life Sciences Business Overview
Table 74. Emmaus Life Sciences Sickle Cell Disease Treatment Product
Table 75. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 76. Emmaus Life Sciences Recent Development
Table 77. Bluebird bio Company Detail
Table 78. Bluebird bio Business Overview
Table 79. Bluebird bio Sickle Cell Disease Treatment Product
Table 80. Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 81. Bluebird bio Recent Development
Table 82. Blood Therapeutics Company Detail
Table 83. Blood Therapeutics Business Overview
Table 84. Blood Therapeutics Sickle Cell Disease Treatment Product
Table 85. Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 86. Blood Therapeutics Recent Development
Table 87. Sangamo Therapeutics Company Detail
Table 88. Sangamo Therapeutics Business Overview
Table 89. Sangamo Therapeutics Sickle Cell Disease Treatment Product
Table 90. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 91. Sangamo Therapeutics Recent Development
Table 92. Acceleron Pharma Company Detail
Table 93. Acceleron Pharma Business Overview
Table 94. Acceleron Pharma Sickle Cell Disease Treatment Product
Table 95. Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 96. Acceleron Pharma Recent Development
Table 97. Arena Pharmaceuticals Company Detail
Table 98. Arena Pharmaceuticals Business Overview
Table 99. Arena Pharmaceuticals Sickle Cell Disease Treatment Product
Table 100. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 101. Arena Pharmaceuticals Recent Development
Table 102. Alnylam Pharmaceuticals Company Detail
Table 103. Alnylam Pharmaceuticals Business Overview
Table 104. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Product
Table 105. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 106. Alnylam Pharmaceuticals Recent Development
Table 107. Sanofi Company Detail
Table 108. Sanofi Business Overview
Table 109. Sanofi Sickle Cell Disease Treatment Product
Table 110. Sanofi Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 111. Sanofi Recent Development
Table 112. CRISPR Therapeutics Company Detail
Table 113. CRISPR Therapeutics Business Overview
Table 114. CRISPR Therapeutics Sickle Cell Disease Treatment Product
Table 115. CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 116. CRISPR Therapeutics Recent Development
Table 117. Vertex Pharmaceuticals, Inc. Company Detail
Table 118. Vertex Pharmaceuticals, Inc. Business Overview
Table 119. Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Product
Table 120. Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 121. Vertex Pharmaceuticals, Inc. Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Disease Treatment Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Sickle Cell Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Sickle Cell Anemia Features
Figure 4. Sickle Beta Thalassemia Features
Figure 5. Sickle Hemoglobin C Disease Features
Figure 6. Global Sickle Cell Disease Treatment Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Sickle Cell Disease Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Sickle Cell Disease Treatment Report Years Considered
Figure 12. Global Sickle Cell Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Sickle Cell Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Sickle Cell Disease Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Sickle Cell Disease Treatment Market Share by Players in 2022
Figure 16. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatment Revenue in 2022
Figure 18. North America Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Sickle Cell Disease Treatment Market Share by Country (2018-2029)
Figure 20. United States Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Sickle Cell Disease Treatment Market Share by Country (2018-2029)
Figure 24. Germany Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Sickle Cell Disease Treatment Market Share by Region (2018-2029)
Figure 32. China Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Sickle Cell Disease Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Sickle Cell Disease Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Sickle Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 47. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 48. Novartis Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 49. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 50. Baxter Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 51. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 52. Bluebird bio Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 53. Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 54. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 55. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 56. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 57. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 58. Sanofi Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 59. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 60. Vertex Pharmaceuticals, Inc. Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed